Clinical Trial Update: The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Tocotrienol Rich Fraction for liver protection in adults with Alcoholic Fatty Liver Disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Fatty Liver Disease

Drugs mentioned

• Tocotrienol Rich Fraction (tocotrienol rich fraction)

Snippet

Sponsor: Universiti Kebangsaan Malaysia Medical Centre | Conditions: Alcoholic Fatty Liver Disease | Phase 2 | Status: RECRUITING